Current reports
6-K
Current report (foreign)
26 Sep 22
6-K
Current report (foreign)
29 Jun 22
6-K
Updated notice to holders of ADSs regarding termination of Deposit Agreement
21 Jun 22
6-K
Current report (foreign)
8 Jun 22
6-K
Current report (foreign)
31 May 22
6-K
Current report (foreign)
23 May 22
6-K
Current report (foreign)
18 May 22
6-K
Updated Financial Calendar for 2022
16 May 22
6-K
Current report (foreign)
16 May 22
6-K
Orphazyme announces update on in-court restructuring proceedings
29 Apr 22
Registration and prospectus
15-12B
Securities registration termination
31 Mar 22
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Mar 22
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Mar 22
POS AM
Prospectus update (post-effective amendment)
21 Mar 22
25
Voluntary exchange delisting
21 Mar 22
424B5
Prospectus supplement for primary offering
4 Nov 21
F-3
Shelf registration (foreign)
15 Oct 21
S-8
Registration of securities for employees
30 Apr 21
S-8
Registration of securities for employees
9 Oct 20
424B4
Prospectus supplement with pricing info
29 Sep 20
Proxies
No filings
Other
EFFECT
Notice of effectiveness
24 Mar 22
EFFECT
Notice of effectiveness
25 Oct 21
CORRESP
Correspondence with SEC
20 Oct 21
UPLOAD
Letter from SEC
20 Oct 21
EFFECT
Notice of effectiveness
29 Sep 20
CORRESP
Correspondence with SEC
28 Sep 20
UPLOAD
Letter from SEC
28 Sep 20
CORRESP
Correspondence with SEC
25 Sep 20
CORRESP
Correspondence with SEC
25 Sep 20
CERT
Certification of approval for exchange listing
24 Sep 20